EMD-34651

Single-particle
3.54 Å
EMD-34651 Deposition: 01/11/2022
Map released: 25/01/2023
Last modified: 25/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-34651

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8hc4 summary report (pdf.gz) Map-8hc4 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up)

EMD-34651

Single-particle
3.54 Å
EMD-34651 Deposition: 01/11/2022
Map released: 25/01/2023
Last modified: 25/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 wildtype spike trimer with three RBD up in complex with three YB9-258 Fab and three R1-32 Fab
Fitted models: 8hc4

Deposition Authors: Liu B, Gao X , Chen Q, Li Z, Su M, He J , Xiong X
Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants.
PUBMED: 36828833
DOI: doi:10.1038/s41467-023-36761-0
ISSN: 2041-1723